relapsed refractory AML

Related by string. * Relapsed . Relapsing . relapser . relapsing : relapsed refractory multiple myeloma . relapsing remitting multiple sclerosis . relapsed ovarian cancer . relapsed multiple myeloma / Refractory : refractory Hodgkin lymphoma . hormone refractory prostate cancer . refractory anemia / Amling . aml . AMLS : acute myeloid leukemia AML . money laundering AML . Money Laundering AML * *

Related by context. Frequent words. (Click for all words.) 67 heavily pretreated 65 mRCC 65 relapsed multiple myeloma 64 relapsed refractory multiple myeloma 64 HER2 positive metastatic breast 64 metastatic hormone refractory 63 docetaxel chemotherapy 63 carboplatin paclitaxel 62 indolent NHL 62 HGS ETR1 61 pertuzumab 61 phase IIb clinical 61 glioblastoma multiforme GBM 61 metastatic renal cell carcinoma 61 acute myelogenous leukemia AML 61 % CI #.#-#.# [007] 60 FOLFIRI 60 chronic HCV infection 60 daunorubicin 60 plus dexamethasone 60 seliciclib 60 chlorambucil 60 Phase Ib clinical 60 Voreloxin 60 KRAS wild 60 multicenter Phase 60 HRPC 60 IMC A# 59 systemic lupus erythematosus SLE 59 % CI #.#-#.# [003] 59 CA4P 59 pancreatic insufficiency 59 chronic lymphocytic leukemia CLL 59 multiple myeloma MM 59 Acute Myeloid Leukemia AML 59 plus gemcitabine 59 Phase 1b 59 plus prednisone 59 leukemia CLL 59 Amrubicin 59 Fibrillex TM 59 relapsing multiple sclerosis 59 ganetespib 59 pheochromocytoma 59 androgen independent 59 acute myeloid leukemia AML 58 ulcerative colitis UC 58 T2DM 58 axitinib 58 dacarbazine 58 diabetic neuropathic pain 58 acute coronary syndromes ACS 58 Fludara 58 dose escalation trial 58 Metastatic Melanoma 58 primary hypercholesterolemia 58 nab paclitaxel 58 Phase 2a clinical 58 lupus nephritis 58 medullary thyroid cancer 58 DOXIL 58 azacitidine 58 R sorafenib tablets 58 Phase 2a trial 58 HCV infected 58 paclitaxel chemotherapy 58 Natalizumab 58 decitabine 58 refractory multiple myeloma 58 plus methotrexate 57 IIa trial 57 Irinotecan 57 Phase 1b trial 57 Gemzar ® 57 Phase 2b study 57 elotuzumab 57 prospectively defined 57 lung fibrosis 57 deforolimus 57 DLBCL 57 Imprime PGG 57 atherothrombosis 57 Phase IIb trials 57 cardiac dysfunction 57 Metastatic Colorectal Cancer 57 lung metastases 57 ADHF 57 double blinded placebo 57 lymphoma CTCL 57 Phase Ib 57 Pivotal Phase 56 placebo controlled Phase 56 relapsed refractory 56 metastatic bone 56 Phase III randomized 56 BAY #-# 56 Phase 2b trial 56 secondary hyperparathyroidism 56 NYHA Class II 56 nasopharyngeal cancer 56 chronic myeloid leukemia CML

Back to home page